Summary
- Current Price
- As of today, DFTX price is $45.40, down -0.92% on
- Current Price All-Time High
- DFTX price is currently -47.54% below its historical high of $86.55 set on
- Market Cap
- DFTX current market cap is $6B, up +751.59% over the past 365 days
- Revenue
- DFTX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for DFTX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Definium Therapeutics, Inc. |
| Ticker | NASDAQ: DFTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | definiumtx.com |
| Employees | 74 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $45.40 | |
| Price, 1D Change | -0.92% | |
| $6B | ||
| - | ||
| - | ||
| 1.10 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.06 | ||
| EPS, 1Y Change | -33.40% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:15 | |
| Next Split | N/A | N/A |
| Last Ticker Change | MNMD | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$2.06 | ||
| EPS Estimate | -$3.13 | N/A |
| EPS Est. Change | -52.13% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $45.40 | |
| Price Target | $66.00 | - |
| Price Tgt. Change | +45.37% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$1.54 | - | |
| -$2.01 | -$2.06 | -2.36% | |
| -$3.13 | N/A | -52.13% | |
| -$1.69 | N/A | +18.10% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $31.42M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $45.40 | |
| $23.30 | ||
| $41.19 | ||
| $26.59 | ||
| $40.20 | ||
| $1.08 | ||
| 1.10 | ||
| $2.84 | ||
| 55.97 | ||
| 69.52% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$2.06 | ||
| $0.00 | ||
| - | ||
| -$166.31M | ||
| - | ||
| -$183.79M | ||
| - | ||
| -$166.31M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.12 | ||
| 6.29 | ||
| 6.29 | ||
| - | ||
| - | ||
| 33.07 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 6.64 | ||
| -22.21 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $332.33M | ||
| $411.59M | ||
| $440.10M | ||
| $419.32M | ||
| $107.77M | ||
| $66.70M | ||
| $40.58M | ||
| $0.00 | ||
| $5.35M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $183.79M | ||
| $166.31M | ||
| $0.00 | ||
| $48.64M | ||
| $0.00 | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$131.56M | ||
| -$151.61M | ||
| $267.27M | ||
| $0.00 | ||
| -$131.56M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Maxim Group | → | |
| Wells Fargo | → | |
| RBC Capital | → | |
| Jones Trading | → | |
| Canaccord Genuity | → | |
| Baird | → | |
| Needham | → | |
| Piper Sandler | → | |
| Wells Fargo | ||
| Piper Sandler | → |
Analyst sentiment
Institutional ownership
Screeners with DFTX
FAQ
- What is the ticker symbol for Definium Therapeutics, Inc.?
- The ticker symbol for Definium Therapeutics, Inc. is NASDAQ:DFTX
- Does Definium Therapeutics, Inc. pay dividends?
- No, Definium Therapeutics, Inc. does not pay dividends
- What sector is Definium Therapeutics, Inc. in?
- Definium Therapeutics, Inc. is in the Healthcare sector
- What industry is Definium Therapeutics, Inc. in?
- Definium Therapeutics, Inc. is in the Biotechnology industry
- What country is Definium Therapeutics, Inc. based in?
- Definium Therapeutics, Inc. is headquartered in United States
- When did Definium Therapeutics, Inc. go public?
- Definium Therapeutics, Inc. initial public offering (IPO) was on November 15, 2016
- Is Definium Therapeutics, Inc. in the S&P 500?
- No, Definium Therapeutics, Inc. is not included in the S&P 500 index
- Is Definium Therapeutics, Inc. in the NASDAQ 100?
- No, Definium Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Definium Therapeutics, Inc. in the Dow Jones?
- No, Definium Therapeutics, Inc. is not included in the Dow Jones index
- When was Definium Therapeutics, Inc. last earnings report?
- Definium Therapeutics, Inc.'s most recent earnings report was on August 6, 2026
- When does Definium Therapeutics, Inc. report earnings?
- The next expected earnings date for Definium Therapeutics, Inc. is November 12, 2026
Data Sources & References
- DFTX Official Website definiumtx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1813814/000119312526076742/0001193125-26-076742-index.htm
- DFTX Profile on Yahoo Finance finance.yahoo.com/quote/DFTX
- DFTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dftx